Quick Answer
AbCellera Biologics Inc. reported Common Stock Shares Outstanding of 300.60 million shares for the year ending 2025.
- AbCellera Biologics Inc. showed an increase of +1.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from AbCellera Biologics Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), AbCellera Biologics Inc.'s Common Stock Shares Outstanding has grown by 11.5%.
- Historical annual values: Fiscal year 2025: 300.60 million shares | Fiscal year 2024: 295.76 million shares | Fiscal year 2023: 290.82 million shares | Fiscal year 2022: 286.85 million shares | Fiscal year 2021: 283.26 million shares | Fiscal year 2020: 269.50 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: